EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 25 June 2020

#WeWontRest in the fight against COVID-19

Our latest statements

Time to step up investments in health systems: EFPIA statement on the EU4Health Programme
22 June 2020

The COVID crisis has shown us the close link between health and wealth. This is the time to step up health investments... Read more

Preparing for a potential second COVID-19 wave
22 June 2020

Joint statement by Medicines for Europe and EFPIA with A.T. Kearney Read more

COVID-19 and Brexit - Protecting patients across Europe from pandemics
19 June 2020

A group of 18 pan-European healthcare stakeholders launched the statement “COVID-19 and Brexit – Protecting patients... Read more

Blogs

EFPIA members' efforts against COVID-19

Janssen
Theresa Pattery thanks all the volunteers that have joined hands to test for Covid-19 diagnostics on the Janssen campus... Read more

Pfizer UK
The COVID-19 pandemic has had a profound impact on everyone in the UK, separating us from our loved ones and taking... Read more

Pfizer Russia
Pfizer Russia supports the Russian healthcare system through monetary support for hospitals treating COVID-19 patients,... Read more

Sanofi & GSK
Sanofi and GSK joined forces in unprecedented vaccine collaboration to fight COVID-19. Listen to Dr Thomas Breuer, Senior... Read more

Did you miss our latest #EFPIATalks? Watch them again!

Diabetes and COVID-19: when two pandemics meet - Integrated care
11 June 2020 (Virtual event)

Rethinking health systems: integrated care and empowerment of primary care Read more

Diabetes and COVID-19: when two pandemics meet: digital health
15 June 2020 (Virtual event)

Engage, define, track, measure, improve: the potential of the digital transformation in diabetes care Read more

United in the search of a COVID-19 vaccine
09 June 2020 (Virtual event)

The first of a series of virtual events dedicated on COVID-19 vaccines and pandemic preparedness Read more

Clinical Trials at the time of COVID-19: And beyond?
19 May 2020 (Virtual event)

On the occasion of International Clinical Trials Day on 20 May, this event seeks to explore the lessons learnt from... Read more

What we are reading

First COVID-19 treatment recommended for EU authorisation
On 25 June 2020 (EMA website)

Remdesivir is the first medicine against COVID-19 to be recommended for authorisation in the EU. Read more

Meet the woman shaping the future of the European Medicines Agency
On 25 June 2020 (Politico)

Emer Cooke will be leading the regulator into a post-pandemic world — one where the EMA may have more powers Read more

IMI launches final IMI2 Calls for proposals
On 23 June 2020 (IMI website)

Topics cover cancer through artificial intelligence, AMR, neurodegenerative diseases, rare disease diagnosis, the return... Read more

Coronavirus: Using European supercomputing, EU-funded research project announces promising...
On 18 June 2020 (European Commission)

The Exscalate4CoV project has gained support from companies in the pharmaceutical industry who provide it with drug... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu